These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 24683506)

  • 1. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
    Bavarsad Shahripour R; Harrigan MR; Alexandrov AV
    Brain Behav; 2014 Mar; 4(2):108-22. PubMed ID: 24683506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology.
    Arakawa M; Ito Y
    Cerebellum; 2007; 6(4):308-14. PubMed ID: 17853088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
    Minarini A; Ferrari S; Galletti M; Giambalvo N; Perrone D; Rioli G; Galeazzi GM
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):279-292. PubMed ID: 27766914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
    Deepmala ; Slattery J; Kumar N; Delhey L; Berk M; Dean O; Spielholz C; Frye R
    Neurosci Biobehav Rev; 2015 Aug; 55():294-321. PubMed ID: 25957927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E
    Karuppagounder SS; Alin L; Chen Y; Brand D; Bourassa MW; Dietrich K; Wilkinson CM; Nadeau CA; Kumar A; Perry S; Pinto JT; Darley-Usmar V; Sanchez S; Milne GL; Pratico D; Holman TR; Carmichael ST; Coppola G; Colbourne F; Ratan RR
    Ann Neurol; 2018 Dec; 84(6):854-872. PubMed ID: 30294906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.
    Dean O; Giorlando F; Berk M
    J Psychiatry Neurosci; 2011 Mar; 36(2):78-86. PubMed ID: 21118657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine.
    Sunitha K; Hemshekhar M; Thushara RM; Santhosh MS; Yariswamy M; Kemparaju K; Girish KS
    Free Radic Res; 2013 May; 47(5):357-67. PubMed ID: 23472882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma.
    Sano H; Namekata K; Kimura A; Shitara H; Guo X; Harada C; Mitamura Y; Harada T
    Cell Death Dis; 2019 Jan; 10(2):75. PubMed ID: 30692515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why.
    Aldini G; Altomare A; Baron G; Vistoli G; Carini M; Borsani L; Sergio F
    Free Radic Res; 2018 Jul; 52(7):751-762. PubMed ID: 29742938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of N-acetylcysteine in neuropsychiatry.
    Berk M; Malhi GS; Gray LJ; Dean OM
    Trends Pharmacol Sci; 2013 Mar; 34(3):167-77. PubMed ID: 23369637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine.
    Altern Med Rev; 2000 Oct; 5(5):467-71. PubMed ID: 11056417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview on the Effects of
    Tardiolo G; Bramanti P; Mazzon E
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30551603
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of N-acetylcysteine and pentoxifylline on remote lung injury in a rat model of hind-limb ischemia/reperfusion injury.
    Takhtfooladi HA; Hesaraki S; Razmara F; Takhtfooladi MA; Hajizadeh H
    J Bras Pneumol; 2016; 42(1):9-14. PubMed ID: 26982035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of N-acetylcysteine in optimization of specific pharmacological therapies].
    Hołyńska-Iwan I; Wróblewski M; Olszewska-Słonina D; Tyrakowski T
    Pol Merkur Lekarski; 2017 Sep; 43(255):140-144. PubMed ID: 28987048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells.
    Chen N; Aleksa K; Woodland C; Rieder M; Koren G
    Transl Res; 2007 Jul; 150(1):51-7. PubMed ID: 17585863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
    Rapado-Castro M; Dodd S; Bush AI; Malhi GS; Skvarc DR; On ZX; Berk M; Dean OM
    Psychol Med; 2017 Apr; 47(5):866-876. PubMed ID: 27894373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats.
    Akbay A; Cinar K; Uzunalimoğlu O; Eranil S; Yurdaydin C; Bozkaya H; Bozdayi M
    Hum Exp Toxicol; 1999 Nov; 18(11):669-76. PubMed ID: 10602391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury.
    Demir S; Inal-Erden M
    Clin Chim Acta; 1998 Jul; 275(2):127-35. PubMed ID: 9721071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.
    Rushworth GF; Megson IL
    Pharmacol Ther; 2014 Feb; 141(2):150-9. PubMed ID: 24080471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafish.
    Faria M; Prats E; Gómez-Canela C; Hsu CY; Arick MA; Bedrossiantz J; Orozco M; Garcia-Reyero N; Ziv T; Ben-Lulu S; Admon A; Gómez-Oliván LM; Raldúa D
    Sci Rep; 2019 Nov; 9(1):16467. PubMed ID: 31712630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.